ResMed Inc $ 172.98 -2.17 (-1.24%)
Volume:
789,059
Avg Vol (1m):
715,156
Market Cap $:
25.02 Bil
Enterprise Value $:
25.86 Bil
P/E (TTM):
40.52
P/B:
10.03
Financial Strength | 7/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.36 | ||
| Equity-to-Asset | 0.54 | ||
| Debt-to-Equity | 0.52 | ||
| Debt-to-EBITDA | 1.36 | ||
| Interest Coverage | 20.16 | ||
| Piotroski F-Score | 6 | ||
| Altman Z-Score | 9.58 | ||
| Beneish M-Score | -2.69 | ||
| WACC vs ROIC | |||
Profitability Rank | 9/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 27.36 | ||
| Net Margin % | 21.02 | ||
| ROE % | 27.75 | ||
| ROA % | 14.31 | ||
| ROC (Joel Greenblatt) % | 76.62 | ||
| 3-Year Revenue Growth Rate | 11.9 | ||
| 3-Year EBITDA Growth Rate | 20.1 | ||
| 3-Year EPS without NRI Growth Rate | 21.2 |
Valuation Rank | 2/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 40.52 | ||
| Forward PE Ratio | 38.28 | ||
| PE Ratio without NRI | 40.52 | ||
| Price-to-Owner-Earnings | 39.1 | ||
| PB Ratio | 10.03 | ||
| PS Ratio | 8.53 | ||
| Price-to-Free-Cash-Flow | 36.18 | ||
| Price-to-Operating-Cash-Flow | 31.39 | ||
| EV-to-EBIT | 33.36 | ||
| EV-to-EBITDA | 27.05 | ||
| EV-to-Revenue | 8.76 | ||
| PEG Ratio | 3.31 | ||
| Shiller PE Ratio | 67.17 | ||
| Current Ratio | 2.53 | ||
| Quick Ratio | 1.84 | ||
| Days Inventory | 110.78 | ||
| Days Sales Outstanding | 58.59 | ||
| Days Payable | 40.43 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Dividend Yield % | 0.91 | ||
| Dividend Payout Ratio | 0.37 | ||
| 3-Year Dividend Growth Rate | 5.7 | ||
| Forward Dividend Yield % | 0.91 | ||
| 5-Year Yield-on-Cost % | 1.27 | ||
| 3-Year Average Share Buyback Ratio | -0.6 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 157.25 | ||
| Price-to-Intrinsic-Value-Projected-FCF | 2.95 | ||
| Price-to-Intrinsic-Value-DCF (Earnings Based) | 2.84 | ||
| Price-to-Median-PS-Value | 1.75 | ||
| Price-to-Peter-Lynch-Fair-Value | 3.58 | ||
| Price-to-Graham-Number | 16.86 | ||
| Earnings Yield (Greenblatt) % | 2.99 | ||
| Forward Rate of Return (Yacktman) % | 13.16 |